Mechanisms of Cognitive Impairment in Depression. May Probiotics Help?
Open Access
- 9 June 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 13, 904426
Abstract
Depression is the major cause of disability globally. Apart from lowered mood and accompanying symptoms, it leads to cognitive impairment that altogether predicts disadvantaged social functioning. Reduced cognitive function in depression appears a bit neglected in the field of clinical and molecular psychiatry, while it is estimated to occur in two-thirds of depressed patients and persist in at least one third of remitted patients. This problem, therefore, requires elucidation at the biomolecular and system levels and calls for improvement in therapeutic approach. In this review study, we address the above-mentioned issues by discussing putative mechanisms of cognitive decline in depression: (1) increased oxidative stress and (2) inflammation, (3) disturbed hypothalamus-pituitary-adrenals axis, and (4) reduced monoamines functionality. Moreover, we acknowledge additional underpinnings of cognitive impairment in depressed elderly: (5) vascular-originated brain ischemia and (6) amyloid-beta plaque accumulation. Additionally, by reviewing molecular, pre-clinical and clinical evidence, we propose gut microbiota-targeted strategies as potential adjuvant therapeutics. The study provides a consolidated source of knowledge regarding mechanisms of cognitive impairment in depression and may path the way toward improved treatment options.Keywords
Funding Information
- Uniwersytet Medyczny w Lodzi
This publication has 139 references indexed in Scilit:
- CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's DiseasePLOS ONE, 2012
- Cognitive Mechanisms of Treatment in DepressionNeuropsychopharmacology, 2011
- Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorderThe British Journal of Psychiatry, 2011
- Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's diseaseThe Lancet Neurology, 2011
- Responders and non-responders to probiotic interventionsGut Microbes, 2010
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-AnalysisPsychosomatic Medicine, 2009
- Neurocognitive Correlates of Response to Treatment in Late-Life DepressionThe American Journal of Geriatric Psychiatry, 2008
- Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generationJournal of Neuroinflammation, 2008
- Psychosocial factors at work and risk of depression: a systematic review of the epidemiological evidenceOccupational and Environmental Medicine, 2008
- Depression and Risk for Alzheimer DiseaseArchives of General Psychiatry, 2006